GO:0098857 membrane microdomain: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098857 membrane microdomain describes a membrane region whose lipid composition is distinct from the surrounding membrane, as defined by QuickGO.
• Membrane microdomains are dynamic, nanoscale lateral heterogeneities whose organization is governed by lipid-lipid and lipid-protein interactions.
• SPFH family proteins, including stomatin, flotillin, and prohibitin, assemble into ring-like or spiral oligomers that shape and stabilize membrane microdomains.
• Cryo-EM of a near-native stretch-sensitive microdomain has revealed how mechanosensitive channels are organized within a defined lipid environment.
• Altered microdomain composition and dynamics are linked to insulin resistance, diabetes-associated cardiac dysfunction, and other membrane-related pathologies.
• Microdomains can be studied with imaging, biochemical fractionation, lipidomics, and CRISPR-based perturbation of their protein and lipid regulators.
Description
Membrane microdomains (GO:0098857) are defined by QuickGO as membrane regions whose lipid composition is distinct from that of the surrounding membrane. This definition places the term at the intersection of membrane biology, lipid biochemistry, and cell signaling, because a change in local lipid composition can alter protein sorting, signaling efficiency, and mechanical properties of the bilayer. Researchers encounter membrane microdomains whenever they study receptor clustering, membrane trafficking, or mechanotransduction, since these processes often depend on the lateral organization of lipids and proteins. The concept has moved from a purely biochemical hypothesis to a structurally characterized entity, with cryo-EM and native mass spectrometry now resolving the architecture of near-native microdomains. At the same time, the dynamic nature of these domains means that their composition and lifetime are sensitive to temperature, membrane tension, and metabolic state, which complicates their experimental definition. For these reasons, GO:0098857 is a useful ontology term for annotating gene products that localize to, shape, or depend on compositionally distinct membrane regions. It also provides a framework for linking membrane organization to disease states such as insulin resistance and diabetic cardiomyopathy.
membrane microdomain At A Glance
| GO ID | GO:0098857 |
|---|---|
| GO term | membrane microdomain |
| Ontology | cellular_component |
| Synonym | none listed in QuickGO |
| Definition | A membrane region with a lipid composition that is distinct from that of the membrane regions that surround it. |
| Major function | Provides a compositionally specialized platform for protein recruitment, signaling, and mechanosensation. |
| Key structural proteins | SPFH family proteins such as stomatin, flotillin, and prohibitin assemble into oligomeric rings that shape microdomains. |
| Dynamic behavior | Microdomains are dynamic entities whose lateral organization responds to membrane potential and tension. |
| Disease relevance | Altered microdomain organization is associated with insulin resistance and diabetes-related cardiac dysfunction. |
What Is GO:0098857?
In plain terms, a membrane microdomain is a patch of a cell membrane that has a different lipid recipe from the membrane around it. QuickGO defines GO:0098857 as a membrane region with a lipid composition that is distinct from that of the membrane regions that surround it. This definition is deliberately composition-based rather than size-based, so it can cover nanoscale assemblies, larger ordered platforms, and specialized membrane subregions. The distinct lipid environment can recruit or exclude specific proteins, thereby creating a functional platform for signaling, transport, or mechanical sensing. Because the definition does not require a particular lipid species, it accommodates cholesterol-enriched, sphingolipid-enriched, or protein-stabilized domains, as long as the local lipid composition differs from the bulk membrane.
Why Is membrane microdomain Important in Cell Biology?
Membrane microdomains matter because they convert a uniform lipid bilayer into a laterally organized surface that can concentrate or separate signaling components, thereby influencing the speed and specificity of cellular responses. Structural work has shown that specific protein scaffolds, such as the human stomatin complex and other SPFH family assemblies, can impose curvature and lipid ordering on the membrane, which in turn affects the distribution of associated proteins. In excitable cells, microdomain organization is sensitive to depolarization and metabolic stress, linking membrane organization to physiological state. Because microdomains participate in receptor signaling, ion transport, and mechanotransduction, they are relevant to diseases ranging from insulin resistance to cardiac ischemia. The term GO:0098857 therefore provides a common vocabulary for annotating genes and proteins whose function depends on a distinct local lipid environment.
• Membrane microdomains create compositionally distinct platforms that can recruit or exclude specific proteins, shaping signal transduction.
• SPFH family proteins such as stomatin and flotillin assemble into ring-like oligomers that stabilize and shape microdomains.
• Cryo-EM of a near-native stretch-sensitive microdomain has revealed how mechanosensitive channels are organized within a defined lipid environment.
• Microdomain organization is dynamic and can be influenced by membrane potential, as shown in yeast plasma membrane studies.
• Altered microdomain properties are linked to insulin resistance and diabetes-associated cardiac dysfunction.
• Microdomains are potential targets for lipid-based therapeutics that aim to modulate membrane organization.
• The term supports annotation of genes involved in membrane trafficking, receptor clustering, and mechanotransduction.
• Microdomain composition can be probed with imaging, lipidomics, and biochemical fractionation, enabling mechanistic studies.
What Happens During membrane microdomain?
Lipid-driven lateral organization
In simple terms: Lipids do not always mix evenly, so they can separate into patches with different compositions.
Membrane microdomains arise when lipid-lipid interactions favor local enrichment of particular lipid species, creating a region whose composition differs from the surrounding bilayer. This lateral organization is dynamic and can be influenced by temperature, membrane tension, and the presence of specific proteins. The QuickGO definition of GO:0098857 captures this composition-based distinction without requiring a specific lipid species.
Protein scaffolding and ring formation
In simple terms: Certain proteins act like frames that hold a patch of membrane together.
SPFH family proteins, including stomatin, flotillin, and prohibitin, assemble into ring-like or spiral oligomers that can shape and stabilize membrane microdomains. Structural studies of a human stomatin complex have provided a basis for understanding how these assemblies form microdomains. Related work on SPFH family proteins has revealed conserved principles of membrane microdomain organization.
Mechanosensation and tension sensitivity
In simple terms: Some microdomains respond to mechanical stretch, helping cells sense force.
Cryo-EM analysis of a near-native stretch-sensitive membrane microdomain has shown how mechanosensitive channels are organized within a defined lipid environment. This structural view links microdomain architecture to the ability of cells to sense and respond to mechanical force. The stretch-sensitive behavior illustrates that microdomains are not static structures but can couple membrane mechanics to protein function.
Dynamic remodeling and environmental sensitivity
In simple terms: Microdomains can change their organization when the cell's environment or electrical state changes.
Depolarization affects the lateral microdomain structure of the yeast plasma membrane, demonstrating that membrane potential can remodel microdomain organization. Theoretical and experimental work has converged on a view of microdomains as dynamic entities whose lifetimes and sizes depend on both biological and physical parameters. These dynamics mean that microdomain composition should be interpreted in the context of the cell's physiological state.
Key Genes Involved in GO:0098857 membrane microdomain
The following genes and proteins are experimentally linked to membrane microdomain organization, function, or disease relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STOM | Stomatin, an SPFH family protein that assembles into ring-like oligomers and shapes membrane microdomains | Structural and functional studies of microdomain formation |
| FLOT1 | Flotillin-1, an SPFH family protein implicated in microdomain organization | Studies of SPFH-mediated membrane microdomain assembly |
| FLOT2 | Flotillin-2, an SPFH family protein that co-assembles with flotillin-1 | Research on microdomain scaffolding and signaling |
| PHB | Prohibitin, an SPFH family protein involved in membrane microdomain organization | Investigation of SPFH family functions in membranes |
| PHB2 | Prohibitin-2, an SPFH family protein with roles in membrane organization | Studies of SPFH oligomerization and microdomains |
| PIEZO1 | Mechanosensitive channel organized within a stretch-sensitive membrane microdomain | Cryo-EM and functional studies of mechanotransduction |
| PIEZO2 | Mechanosensitive channel related to stretch-sensitive microdomain biology | Research on mechanosensitive microdomain organization |
| INSR | Insulin receptor, whose signaling is influenced by membrane microdomain organization | Studies linking microdomains to insulin resistance |
| GLUT4 | Glucose transporter whose trafficking and function relate to membrane microdomain dynamics | Research on insulin resistance and membrane microdomain disorders |
| CAV1 | Caveolin-1, a membrane protein associated with compositionally distinct membrane regions | Investigation of membrane microdomain composition and dynamics |
| CAV2 | Caveolin-2, a membrane protein linked to microdomain organization | Studies of membrane microdomain structure |
| SLC2A4 | Solute carrier family 2 member 4, related to insulin-responsive membrane dynamics | Research on insulin resistance as a membrane microdomain disorder |
| ATP1A1 | Na+/K+-ATPase, whose membrane environment can be influenced by microdomain organization | Studies of myocyte membrane microdomain modifications in diabetes |
| SCN5A | Voltage-gated sodium channel, relevant to excitable membrane microdomain biology | Research on cardiac membrane microdomain modifications |
| KCNH2 | Potassium channel, relevant to myocyte membrane microdomain function | Studies of diabetes-associated cardiac membrane changes |
| GJA1 | Connexin 43, a gap junction protein associated with membrane microdomains | Research on myocyte membrane microdomain modifications |
| LYN | Src-family kinase, a signaling protein often associated with membrane microdomains | Investigation of microdomain-dependent signaling |
| LCK | Src-family kinase, a signaling protein linked to membrane microdomain function | Studies of membrane microdomain signaling platforms |
How Is membrane microdomain Regulated?
Membrane microdomain organization is regulated by a combination of lipid composition, protein scaffolding, and physical parameters such as membrane tension and potential. SPFH family proteins can assemble into oligomeric structures that shape and stabilize microdomains, providing a protein-based regulatory mechanism. Environmental and physiological changes, including depolarization, can remodel microdomain structure, as shown in yeast plasma membrane studies. In metabolic disease, altered lipid handling and insulin signaling are associated with changes in microdomain organization, suggesting that systemic metabolic state can regulate microdomain properties. Lipid-based therapeutic approaches aim to modulate microdomain organization, further supporting the idea that microdomain composition is a regulated and targetable parameter.
membrane microdomain and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INSR | Insulin resistance as a membrane microdomain disorder | Knockout or point-mutation cell models to study insulin signaling in altered microdomains |
| SLC2A4 | Insulin-responsive glucose transport and membrane microdomain dynamics | Knock-in or overexpression models to track GLUT4 trafficking |
| STOM | Microdomain formation and membrane organization | Knockout and tagged knock-in models to study stomatin oligomerization |
| PIEZO1 | Mechanotransduction within stretch-sensitive microdomains | Point-mutation and knockout models to test mechanosensitive channel function |
| CAV1 | Membrane microdomain composition and signaling | Overexpression and knockout models to probe caveolin-dependent microdomains |
Insulin resistance and metabolic disease
Insulin resistance has been described as a membrane microdomain disorder, in which altered microdomain organization contributes to impaired insulin signaling. Myocyte membrane and microdomain modifications in diabetes are determinants of ischemic tolerance and cardioprotection, linking microdomain biology to diabetic heart disease. These observations suggest that therapies targeting microdomain composition could influence metabolic and cardiac outcomes.
Cardiac dysfunction and ischemia
In diabetes, modifications to myocyte membranes and microdomains affect ischemic tolerance and cardioprotection, indicating that microdomain organization is relevant to cardiac stress responses. Because microdomains can organize ion channels and signaling proteins, changes in their composition may influence electrical and mechanical function of the heart. Research in this area aims to identify microdomain-dependent mechanisms that could be targeted to protect the myocardium.
Membrane-related therapeutic targeting
Lipid drugs that target transient membrane microdomains have been explored as therapeutic strategies, highlighting the potential of modulating microdomain composition. Such approaches aim to alter the lipid environment rather than a single protein, which may be useful when microdomain dysfunction involves multiple components. The concept of transient microdomain-targeted lipid therapeutics is still under investigation but represents a direct link between GO:0098857 and drug development.
From membrane microdomain-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene shape membrane microdomain composition? | Knockout cell model combined with lipidomics and imaging |
| Does a specific residue control microdomain localization? | Point-mutation knock-in cell model with tagged protein |
| Does a protein assemble into microdomain-associated oligomers? | Tagged knock-in model for structural and biochemical analysis |
| Does overexpression of a microdomain protein alter signaling? | Overexpression cell model with pathway readouts |
| Which genes regulate microdomain dynamics under stress? | CRISPR library screening with imaging-based readouts |
| How does a disease-associated variant affect microdomain function? | Point-mutation knock-in model in a relevant cell type |
How to Study the membrane microdomain Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Lateral organization and dynamics of labeled microdomain components | Live-cell imaging of microdomain remodeling |
| Cryo-EM | Near-native architecture of membrane microdomains and protein assemblies | Structural analysis of stretch-sensitive or SPFH-containing microdomains |
| Lipidomics | Lipid composition of membrane fractions | Testing whether a membrane region has a distinct lipid profile |
| Biochemical fractionation | Separation of compositionally distinct membrane fractions | Isolating microdomain-enriched fractions for analysis |
| CRISPR knockout | Loss-of-function effects on microdomain organization | Testing candidate genes for microdomain roles |
| CRISPR point mutation | Effect of specific residues on microdomain function | Dissecting protein domains involved in microdomain assembly |
| Overexpression | Gain-of-function effects on microdomain composition | Testing whether a protein is sufficient to alter microdomains |
| CRISPR library screening | Identification of genes regulating microdomain phenotypes | Unbiased discovery of microdomain regulators |
Imaging of membrane microdomains
Advanced imaging approaches can visualize the lateral organization of membrane microdomains in live or fixed cells. These methods help researchers observe how microdomain structure changes with environmental or genetic perturbations. Imaging is often combined with fluorescently tagged proteins to map microdomain-associated components.
Biochemical fractionation and lipidomics
Biochemical fractionation can isolate detergent-resistant or compositionally distinct membrane fractions, providing a biochemical handle on microdomains. Lipidomics can then quantify the lipid composition of these fractions to test whether they meet the QuickGO definition of a distinct lipid environment. Such approaches are useful for validating candidate microdomain regulators identified by genetic screens.
Structural biology of microdomain assemblies
Cryo-EM and related structural methods have resolved the architecture of near-native membrane microdomains and SPFH protein assemblies. These techniques reveal how protein oligomers shape lipid bilayers and organize associated components. Structural insights can guide mutational studies to test the functional importance of specific interfaces.
Genetic perturbation and screening
CRISPR-based knockout, point-mutation, and overexpression models allow researchers to test the causal role of specific genes in microdomain organization. Library screening can identify new regulators of microdomain composition or dynamics when combined with appropriate readouts. These genetic approaches complement imaging and biochemical methods by establishing causality.
How CRISPR Can Be Used to Study GO:0098857 membrane microdomain
Knockout
CRISPR knockout cell models can remove a candidate gene to test whether it is required for membrane microdomain formation or maintenance. By comparing knockout and wild-type cells with imaging or lipidomics, researchers can determine whether the gene product contributes to a compositionally distinct membrane region. Knockout models are also useful for validating hits from library screens.
Point Mutation
Point-mutation knock-in models allow precise testing of residues predicted to mediate microdomain localization or protein-protein interactions. Such models are valuable when a disease-associated variant is suspected to alter microdomain function. By introducing a single amino acid change, researchers can separate microdomain-related functions from other roles of the protein.
Knock-in
Tagged knock-in models enable endogenous labeling of microdomain proteins for imaging and biochemical analysis. These models preserve native expression levels and regulation, which is important for studying dynamic microdomain behavior. Knock-in approaches can also be used to introduce disease-relevant mutations for functional studies.
Overexpression
Overexpression models can test whether increasing the level of a protein is sufficient to alter membrane microdomain composition or signaling. They are particularly useful for studying proteins that are normally present at low abundance. Overexpression should be interpreted alongside knockout data to establish causality.
How EDITGENE Supports membrane microdomain Research
Researchers studying membrane microdomain-related genes often need to determine whether a candidate gene is causally involved in shaping a compositionally distinct membrane region, or whether its association is secondary to other cellular changes. Establishing causality typically requires precise genetic perturbation combined with imaging, lipidomics, or signaling readouts. EDITGENE provides a suite of CRISPR-based services designed to support this workflow, from knockout and point-mutation models to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for membrane microdomain research.
Frequently Asked Questions About membrane microdomain
What is a membrane microdomain?
A membrane microdomain is a membrane region whose lipid composition is distinct from that of the surrounding membrane, as defined by GO:0098857.
What is GO:0098857?
GO:0098857 is the Gene Ontology cellular_component term for membrane microdomain, defined as a membrane region with a lipid composition distinct from surrounding regions.
What genes are involved in membrane microdomains?
Genes encoding SPFH family proteins such as STOM, FLOT1, FLOT2, PHB, and PHB2 are involved in microdomain organization, along with mechanosensitive channels like PIEZO1.
How are membrane microdomains formed?
They form through lipid-lipid interactions and protein scaffolding, with SPFH family proteins assembling into ring-like oligomers that shape the membrane.
Why are membrane microdomains important in disease?
Altered microdomain organization is linked to insulin resistance, diabetes-associated cardiac dysfunction, and other membrane-related pathologies.
How can I study membrane microdomains in the lab?
Common approaches include fluorescence imaging, cryo-EM, lipidomics, biochemical fractionation, and CRISPR-based genetic perturbation.
What is the role of stomatin in membrane microdomains?
Stomatin is an SPFH family protein that assembles into ring-like oligomers and helps shape membrane microdomains.
Are membrane microdomains the same as lipid rafts?
The GO term is composition-based and does not require a specific lipid species, so it can encompass various compositionally distinct membrane regions, including but not limited to classical lipid raft descriptions.
Can membrane microdomains be targeted therapeutically?
Lipid drugs targeting transient membrane microdomains have been explored as therapeutic strategies, though this area is still under investigation.
What CRISPR models are useful for microdomain research?
Knockout, point-mutation knock-in, tagged knock-in, and overexpression models can all be used to test the causal role of genes in microdomain organization.
Conclusion
GO:0098857 membrane microdomain provides a precise, composition-based definition for a membrane region whose lipid environment differs from its surroundings. Structural and dynamic studies have shown that these regions are shaped by lipid-lipid interactions and protein scaffolds such as SPFH family oligomers, and that they can respond to mechanical and electrical cues. Their relevance to insulin resistance, cardiac dysfunction, and other diseases makes them an active area of research. CRISPR-based models, combined with imaging and lipidomics, offer a powerful way to establish causality and identify new regulators of membrane microdomains.
References
- 1. Kefauver JM et al.. 2024. Cryo-EM architecture of a near-native stretch-sensitive membrane microdomain.. Nature 632(8025):664-671 PMID: 39048819
- 2. Schneider Alves AC et al.. 2022. Uncovering the Potential of Lipid Drugs: A Focus on Transient Membrane Microdomain-targeted Lipid Therapeutics.. Mini Rev Med Chem 22(18):2318-2331 PMID: 35264091
- 3. Russell J et al.. 2017. Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.. Cardiovasc Diabetol 16(1):155 PMID: 29202762
- 4. Stoner J et al.. 2025. Structural basis for membrane microdomain formation by a human Stomatin complex.. Nat Commun 16(1):7439 PMID: 40796562
- 5. Ma C et al.. 2022. Structural insights into the membrane microdomain organization by SPFH family proteins.. Cell Res 32(2):176-189 PMID: 34975153
- 6. Destainville N et al.. 2016. Where Biology Meets Physics--A Converging View on Membrane Microdomain Dynamics.. Curr Top Membr 77:27-65 PMID: 26781829
- 7. Inokuchi J. 2007. Insulin resistance as a membrane microdomain disorder.. Yakugaku Zasshi 127(4):579-86 PMID: 17409686
- 8. Herman P et al.. 2015. Depolarization affects the lateral microdomain structure of yeast plasma membrane.. FEBS J 282(3):419-34 PMID: 25410771
